Your browser doesn't support javascript.
loading
Prospective analysis of liquid biopsies of advanced non-small cell lung cancer patients after progression to targeted therapies using GeneReader NGS platform.
Mayo de Las Casas, Clara; Garzón-Ibañez, Mónica; Jordana-Ariza, Núria; Viteri-Ramírez, Santiago; Moya-Horno, Irene; Karachaliou, Niki; Yeste, Zaira; Campos, Raquel; Villatoro, Sergi; Balada-Bel, Ariadna; García-Peláez, Beatriz; Reguart, Noemí; Teixidó, Cristina; Jantús, Eloisa; Calabuig, Silvia; Aguado, Cristina; Giménez-Capitán, Ana; Román-Lladó, Ruth; Pérez-Rosado, Ana; Catalán, Maria José; Bertrán-Alamillo, Jordi; García-Román, Silvia; Rodriguez, Sonia; Alonso, Lidia; Aldeguer, Erika; Martínez-Bueno, Alejandro; González-Cao, Maria; Aguilar Hernandez, Andrés; Garcia-Mosquera, Juan; de Los Llanos Gil, Maria; Fernandez, Manuel; Rosell, Rafael; Molina-Vila, Miguel Ángel.
  • Mayo de Las Casas C; Laboratory of Oncology, Pangaea Oncology, Quirón Dexeus University Hospital, Barcelona, Spain.
  • Garzón-Ibañez M; Laboratory of Oncology, Pangaea Oncology, Quirón Dexeus University Hospital, Barcelona, Spain.
  • Jordana-Ariza N; Laboratory of Oncology, Pangaea Oncology, Quirón Dexeus University Hospital, Barcelona, Spain.
  • Viteri-Ramírez S; Dr Rosell Oncology Institute (IOR), Quirón Dexeus University Hospital, Barcelona, Spain.
  • Moya-Horno I; Dr Rosell Oncology Institute (IOR), QuironSalud group, General Hospital of Catalonia, Sant Cugat del Vallés, Spain.
  • Karachaliou N; Dr Rosell Oncology Institute (IOR), QuironSalud group, University Hospital Sagrat Cor, Barcelona, Spain.
  • Yeste Z; Laboratory of Oncology, Pangaea Oncology, Quirón Dexeus University Hospital, Barcelona, Spain.
  • Campos R; Laboratory of Oncology, Pangaea Oncology, Quirón Dexeus University Hospital, Barcelona, Spain.
  • Villatoro S; Laboratory of Oncology, Pangaea Oncology, Quirón Dexeus University Hospital, Barcelona, Spain.
  • Balada-Bel A; Laboratory of Oncology, Pangaea Oncology, Quirón Dexeus University Hospital, Barcelona, Spain.
  • García-Peláez B; Laboratory of Oncology, Pangaea Oncology, Quirón Dexeus University Hospital, Barcelona, Spain.
  • Reguart N; Department of Medical Oncology, Hospital Clínic, Barcelona, Spain.
  • Teixidó C; Department of Medical Oncology, Hospital Clínic, Barcelona, Spain.
  • Jantús E; Molecular Oncology Laboratory, Fundación Investigación, Hospital General Universitario de Valencia, Valencia, Spain.
  • Calabuig S; Centro de Investigación Biomédica en Red de Cáncer (CIBEROnc), Madrid, Spain.
  • Aguado C; Department of Pathology, Universitat de València, Valencia, Spain.
  • Giménez-Capitán A; Molecular Oncology Laboratory, Fundación Investigación, Hospital General Universitario de Valencia, Valencia, Spain.
  • Román-Lladó R; Centro de Investigación Biomédica en Red de Cáncer (CIBEROnc), Madrid, Spain.
  • Pérez-Rosado A; Department of Pathology, Universitat de València, Valencia, Spain.
  • Catalán MJ; Laboratory of Oncology, Pangaea Oncology, Quirón Dexeus University Hospital, Barcelona, Spain.
  • Bertrán-Alamillo J; Laboratory of Oncology, Pangaea Oncology, Quirón Dexeus University Hospital, Barcelona, Spain.
  • García-Román S; Laboratory of Oncology, Pangaea Oncology, Quirón Dexeus University Hospital, Barcelona, Spain.
  • Rodriguez S; Laboratory of Oncology, Pangaea Oncology, Quirón Dexeus University Hospital, Barcelona, Spain.
  • Alonso L; Laboratory of Oncology, Pangaea Oncology, Quirón Dexeus University Hospital, Barcelona, Spain.
  • Aldeguer E; Laboratory of Oncology, Pangaea Oncology, Quirón Dexeus University Hospital, Barcelona, Spain.
  • Martínez-Bueno A; Laboratory of Oncology, Pangaea Oncology, Quirón Dexeus University Hospital, Barcelona, Spain.
  • González-Cao M; Laboratory of Oncology, Pangaea Oncology, Quirón Dexeus University Hospital, Barcelona, Spain.
  • Aguilar Hernandez A; Cellex Centre, Vall d'Hebrón, Institute of Oncology, Barcelona, Spain.
  • Garcia-Mosquera J; Laboratory of Oncology, Pangaea Oncology, Quirón Dexeus University Hospital, Barcelona, Spain.
  • de Los Llanos Gil M; Dr Rosell Oncology Institute (IOR), Quirón Dexeus University Hospital, Barcelona, Spain.
  • Fernandez M; Dr Rosell Oncology Institute (IOR), Quirón Dexeus University Hospital, Barcelona, Spain.
  • Rosell R; Dr Rosell Oncology Institute (IOR), Quirón Dexeus University Hospital, Barcelona, Spain.
  • Molina-Vila MÁ; Dr Rosell Oncology Institute (IOR), Quirón Dexeus University Hospital, Barcelona, Spain.
Transl Cancer Res ; 8(Suppl 1): S3-S15, 2019 Jan.
Article en En | MEDLINE | ID: mdl-35117060
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Año: 2019 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Año: 2019 Tipo del documento: Article